Le Lézard
Classified in: Health
Subjects: PET, FVT

Heska to Present at the Upcoming Stifel 2022 Jaws and Paws Conference


LOVELAND, Colo., May 25, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the Stifel 2022 Jaws and Paws Conference at the Pierre New York Hotel in New York City on Wednesday, June 1, 2022 at 3:00 p.m. Eastern Time.

Mr. Wilson's presentation and the subsequent question and answer session can be accessed at https://wsw.com/webcast/stifel72/hska/2079792. The webcast and presentation will be archived on Heska's website shortly after the event and the replay will be available for 90 days.

Mr. Wilson and members of Heska management will also be participating in one-on-one investor meetings on June 1st. For questions and more information, please contact Stifel at [email protected] or Heska Investor Relations at [email protected].

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

SOURCE Heska Corporation


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: